More reads
- New MS drug from Biogen and Alkermes wins approval. (Boston Globe)
- California wildfires and power outages cause disruptions for scientists. (Nature)
- Insurance, pharma figures spar over drug price legislation’s innovation impact. (STAT Plus)
- New details emerge in case of first death from fecal transplant. (STAT)
No hay comentarios:
Publicar un comentario